EME
EMCOR Group, Inc.Evidence as of 2026-09-02Moneyta sentiment
Where the published evidence leans after the desk debated it — not a rating or a recommendation.
+0.5 on a −2 to +2 scale.
What builds the score
Solid bars are analyst rubric scores; faded bars are computed directly from data. Claims dropped in debate count for nothing; weakened claims count at half weight.
Editor's note
Written after the debate settled — the rest of the page is the evidence behind it.
What the evidence shows
The evidence balance is Constructive (+0.5 of a possible +2; was +0.5 before debate) with high confidence. Revenues rose from $ 3,867,372,000 in fiscal Q1 2025 (fiscal quarter ended 2025-04-24) to $ 5,154,892,000 in fiscal Q2 2026 (fiscal quarter ended 2026-07-24), and gross profit increased to $ 1,022,379,000 in fiscal Q2 2026. Calculated gross margin expanded from about 18.7% in fiscal Q1 2025 to about 19.8% in fiscal Q2 2026, and operating income climbed from $ 318,756,000 in fiscal Q1 2025 to $ 547,340,000 in fiscal Q2 2026. Ownership and news items show institutional buying and mixed sentiment, and valuation metrics include a P/E (ttm) of 25.15 and a price-to-free-cash-flow of 693.57.
What the debate changed
The desk left the read largely intact; nothing was dropped. The only claim weakened during debate was the share-count/repurchase detail: weighted average diluted shares declined from 45,784,235 in fiscal Q1 2025 to 44,452,894 in fiscal Q2 2026, and the company recorded $ 224,832,000 of repurchases in fiscal Q1 2026, but that specific element carried reduced force after scrutiny. That weakening narrowed how strongly the analysts could credit buybacks for per-share improvements, without materially shifting the constructive evidence on revenue, margin and operating-income growth.
How this note was made
every stage ran before the note was writtenAnalyst desk
Mercer, Oakes, Nash, Ellis, Yates, Talbot and Archer. The desk: named AI agents, not people. Each reads one slice of the evidence and nothing else — no outside knowledge, no browsing — so every finding traces to a source you can open.
Reads the XBRL figures companies file with the SEC — revenue, margins, income, debt and share count, quarter by quarter — and reports which way the trend is running.
Revenues were $5,154,892,000 in fiscal Q2 2026 (2026-04-01 to 2026-06-30, 3mo).
XBRL companyfacts · 0000105634-26-000110Revenues were $3,867,372,000 in fiscal Q1 2025 (2025-01-01 to 2025-03-31, 3mo), showing a rise to $5,154,892,000 by fiscal Q2 2026.
XBRL companyfacts · 0000105634-25-000029Reads the filings themselves, above all the year-over-year diff of Item 1A risk factors: which risks a company added, dropped or quietly reworded since its last annual report.
Nothing in this slice of the evidence rose to a claim — a quiet read, which itself is information.
Which filings the desk reads
The desk reads the annual 10-K in full — its risk factors, and how they changed since last year. Quarterly 10-Qs and event filings (8-Ks, insider Form 4s) are listed for context but not read line by line: the 10-K is where the material risk disclosures live. A brand-new company, or one we have only just begun tracking, may have no annual report on file yet — its risk analysis fills in once that lands.
Reads the signal panel above — momentum, volatility, drawdown, relative strength and beta — and ranks each against the whole research universe rather than judging it in isolation.
No computed signal history for this symbol yet — signals need roughly 70 trading days of price history.
Reads which funds hold the name and at what weight, plus insider Form 4 filings, to show the exposure you may already carry through index funds.
As of 2026-09-02T13:45:47.228469+00:00, EME appears as a holding in the ETF with symbol IVV at a weight of 0.06% of that fund.
ETF constituents · market dataThe provided record is a single ETF membership data point for EME in IVV dated 2026-09-02T13:45:47.228469+00:00 and does not include additional ETF holdings, historical weight changes, or insider Form 4 events.
ETF constituents · market dataReads recent headlines that are genuinely about this company, ignoring rating chatter and market-wide stories. Findings argue in the debate but never move the sentiment score.
Coverage in multiple outlets is focusing on EMCOR's building services growth and the potential for further margin expansion.
News · zacks.com · 2026-09-02A news item reports that Railway Pension Investments Ltd raised its holdings in EMCOR in the second quarter, increasing its stake by 13.1%.
News · thelincolnianonline.com · 2026-09-01Reads parsed Forms 3/4/5 — who bought or sold, at what size, and whether a 10b5-1 plan was involved. Flags clustered open-market officer buying; treats plan sales as routine and never counts a fund or 10%-holder as an officer.
No insider transactions on file in the trailing 180 days.
Reads the implied-expectations math built from the company's own filings (the growth rate today's price would justify, and the multiples beside it) and argues whether the market's bar looks high or low for this business. Never turns the math into a target.
The price-to-free-cash-flow ratio is 693.57 (price 734.26 divided by FCF per share 1.0587).
Valuation inputs · SEC XBRL + stored EOD closeThe trailing twelve-month price-to-earnings ratio is 25.15, based on EPS (ttm) of 29.19 and the given price.
Valuation inputs · SEC XBRL + stored EOD closeDebate and risk review
A bull and a bear contest the claims and the chair rules on each; the risk review stress-tests what survived.
A bull and a bear argue the analysts' claims across two rounds, then a chair rules on each one. Only what survives feeds the score — the argument is shown, not hidden, so you can judge the reasoning yourself.
Recent company filings show material top-line growth (Q1 2025 to Q2 2026) together with expanding gross margin and rising operating income, and the firm recorded meaningful share repurchases while diluted shares fell; these operating and capital-return signals support a favorable operational read. Multiple news items and reported institutional purchases accompany several buy-side analyst ratings, which together indicate positive market and professional-interest signals alongside the reported results. The most significant valuation negatives hinge on very low trailing free-cash-flow relative to price and a very high P/FCF; however, those valuation datapoints sit alongside strong operating-income figures and margin expansion, suggesting the FCF shortfall may be a timing or conversion issue rather than a pure-operating weakness. Therefore, the operational evidence and institutional/analyst interest jointly support a constructive interpretation of the company’s recent performance while the valuation datapoints warrant closer scrutiny of FCF conversion metrics and timing.
Chair's verdict, claim by claim
Fragility · computed, not argued
balanced0.31
19 surviving claims rest on 11 distinct sources; the heaviest analyst carries 32% of them, and 97% of what the desk raised survived the debate.
The evidence set rests on a modest number of distinct sources and a single analyst provided nearly one-third of the surviving claims, so conclusions are moderately source-concentrated. The very high survival rate from the desk debate means most points stood scrutiny, but because many claims trace back to the same few inputs a new, contradictory filing or a corrected primary document would materially reduce confidence in the overall read.
Disconfirming evidence · base rates · falsifiers
Context
Outside consensus, and where this name already sits in your own portfolio.
Third-party consensus shown for context. It never enters Moneyta sentiment — when the two diverge, the debate above is where the why lives.
What this was built from
Every figure on this page traces to one of these. The desk reads only what is listed here — no outside knowledge, no browsing — and each card shows who read it and what it contributed to the score.
13 filings· 2 cited
SEC XBRL filings
Quarterly figures as filed with the SEC, read straight from EDGAR's structured data — not retyped or estimated.
Read by Mercer+1.0 to the score
1 holdings record
Fund holdings
Which funds hold this name and at what weight, plus insider Form 4 filings.
Read by Ellis+0.0 to the score
8 headlines· 2 cited
News coverage
Recent headlines about this company, rating chatter excluded and nothing published after the report date.
Read by Yatesnothing survived
1 computation
Valuation inputs
TTM cash-flow figures from the company's own XBRL filings, priced with the stored closing price. Implied growth and multiples only; no fair-value dollar figure reaches the desk, by design.
Read by Archercontext only
1 record· 0 cited
Company profile
Sector, industry and company details.
1 record· 0 cited
Analyst consensus
Third-party consensus, shown for context only — it never enters Moneyta sentiment.
Read means we pulled and handed it to an analyst; cited means a claim on this page points at it. Reading twelve quarters to state one trend is normal — the gap is shown rather than hidden.
Written by AI, checked against sources
The analysts, the bull–bear debate and the editor's note are AI agents reading only the evidence listed on this page. They can misread a filing or a headline, which is why every claim cites a source you can open and check yourself. The sentiment score is arithmetic over the claims that survived the debate, not a language model's opinion.
Educational analysis of published data. Moneyta does not give investment advice or make recommendations. Past patterns do not indicate future results.
Get this for the tickers you actually hold
Plus the one thing no sample can show: how each name correlates with your portfolio, and what hides inside your funds.
The full terminal on EME Gold
Who holds it, who's buying, what the Street thinks: live behind the lock, updated as filings land.
Institutional holders
Net institutional flow, Q/Q
Largest holder position
Insider buys, 90 days
Clustered insider value
Street target range
The real figures are for members. Educational analysis, not advice.
Educational analysis of published data. Moneyta does not give investment advice or make recommendations.